A commitment to a better you.
Non-surgical treatments that help eliminate facial wrinkles and folds, and give you longer, fuller lashes. These treatments can be used in combination to address the forehead, eyebrows, eyes and cheeks. Our certified doctors and nurse injectors have extensive experience with all of the options, and we maintain ongoing staff education so that every procedure is performed safely.
BOTOX® Cosmetic
Relaxes the muscles that create frown lines and wrinkles on the forehead, between the brows and around the eyes.
Read moreJUVÉDERM®
A smooth injectable gel filler that smooths lines and restores lost volume to the cheeks and jawline.
Read moreLATISSE®
The first FDA-approved prescription treatment for inadequate eyelashes — longer, fuller and darker lashes.
Read moreBOTOX® Cosmetic treatments
BOTOX® has fast become the cosmetic treatment of choice.
Description and procedure
BOTOX® is the brand name for a chemical produced from the Clostridium botulinum bacterium. In April 2002 the FDA approved the use of BOTOX® for the treatment of moderate to severe frown lines between the eyebrows; it has been used for other medical conditions since 1989.
A BOTOX® cosmetic treatment is a non-surgical medical procedure. Our physician injects small amounts of BOTOX® into the troublesome line or wrinkle area. These injections relax the muscles there and prevent them from contracting, so the area appears more relaxed and smoother.
The procedure is quick — about ten minutes per treatment. There is very little discomfort and no anesthesia is necessary. It takes anywhere from three days to a week to notice the change.
The line areas that respond best are the forehead, the eyes and the frown lines between the brows. Wrinkles caused by sun damage do not respond well to BOTOX® treatments.
Follow-up treatments
Results last anywhere from three to six months. Everyone is different — when you notice the lines reappearing, it may be time for another treatment. Over time, as your muscles learn to relax, fewer intense lines may appear.
How to prepare
Bruising is a common side effect, and taking aspirin or other anti-inflammatory medications in the two weeks before treatment can make it worse. We also advise that you do not drink alcohol for at least one week prior to your treatment.
JUVÉDERM® injectable gel filler
Everyone will notice, but no one will know.
What is JUVÉDERM®?
JUVÉDERM® is a smooth, replenishing injectable gel filler used to refresh your appearance. We smooth away unwanted lines and bring back the natural contours of your face, with smooth and natural-looking results that last up to a year.†
Its exclusive formulation uses hyaluronic acid, a naturally occurring sugar found in your body. It combines with the water in your skin to smooth lines and wrinkles, enhance lips, and restore lost volume to the cheeks and jawline. Hyaluronic acid facial fillers can even naturally stimulate collagen production in your skin.1
Where does it work?
Everyone's skin ages differently, and JUVÉDERM® may be used to rejuvenate multiple problem areas.* From smile lines to vertical lip lines, you can smooth away unwanted wrinkles and restore natural contours.
It is long lasting
JUVÉDERM® is the only hyaluronic acid filler FDA approved* to last up to one year with one treatment.†
Important safety information
JUVÉDERM® XC injectable gel is available by prescription only. Please read the information below, and ask us any question you have at your consultation.
JUVÉDERM® XC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.
JUVÉDERM® XC injectable gel should not be used in patients who have severe allergies marked by a history of anaphylaxis, or a history or presence of multiple severe allergies. It should not be used in patients with a history of allergies to gram-positive bacterial proteins or to lidocaine.
JUVÉDERM® XC injectable gel must not be injected into blood vessels and should not be used in vascular-rich areas. Use in these areas, such as the glabella and nose, has resulted in cases of vascular embolization, occlusion of the vessels, ischemia or infarction, or blindness. Symptoms of vessel occlusion and embolization include pain that is disproportionate to the procedure or remote to the injection site, immediate blanching extending beyond the injected area, and colour changes that reflect ischemic tissue such as a dusky or reticular appearance.
Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes or hives) or infection is present should be deferred until the underlying process has been controlled.
- The safety and effectiveness for treatment of anatomic regions other than facial wrinkles and folds (such as lips) have not been established.
- As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials.
- The safety for use during pregnancy and in breastfeeding females has not been established.
- The safety for use in patients under 18 years has not been established.
- The safety in patients with known susceptibility to keloid formation, hypertrophic scarring and pigmentation disorders has not been studied.
- Should be used with caution in patients on immunosuppressive therapy.
- Patients using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs and warfarin) may experience increased bruising or bleeding at treatment sites.
- Patients should be limited to 20 mL of JUVÉDERM® XC per 60 kg (130 lbs) body mass per year. The safety of injecting greater amounts has not been established.
The most commonly reported side effects are temporary injection-site redness, swelling, pain or tenderness, firmness, lumps and bumps, bruising, discolouration and itching. Most side effects are mild or moderate in nature, lasting seven days or less.
To report a problem with JUVÉDERM® XC, please call Allergan Product Surveillance at 1-800-624-4261. For more information, see the About Safety page at juvederm.com or call the Allergan Medical Information line at 1-800-433-8871.
† This includes all JUVÉDERM® injectable gel formulations. Most subjects acquired optimal correction at initial treatment.
* In the United States, JUVÉDERM® is indicated for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.
1 Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, Voorhees JJ. In Vivo Stimulation of De Novo Collagen Production Caused by Cross-linked Hyaluronic Acid Dermal Filler Injections in Photodamaged Human Skin. Arch Dermatol. 2007 Feb;143:155–163.
LATISSE® for longer, fuller lashes
Discover the LATISSE® difference.
LATISSE® solution is a growth treatment for lashes, and the first FDA-approved prescription treatment for inadequate or not enough eyelashes. It grows lashes longer, fuller and darker. It is not an illusion of growth — it is real eyelash growth.
How LATISSE® works
Lash growth is made possible by its active ingredient, bimatoprost. LATISSE® is a once-nightly treatment applied topically to the base of your upper eyelashes. You may start to see more length in as little as four weeks, and should achieve full growth in sixteen weeks.
The history behind it
LATISSE® was created by Allergan, a pharmaceutical leader with sixty years of eye-care expertise. In 2001 Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using it also began to grow longer, fuller and darker lashes as a side effect. That led Allergan to study the active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE® was approved by the FDA in December 2008.
Important safety information
LATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness and darkness.
In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN® for IOP reduction should only use LATISSE® after consulting with their physician, and should be monitored for changes to their intraocular pressure.
Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.
Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes. The pigmentation is expected to increase as long as bimatoprost is administered, but has been reported to be reversible upon discontinuation in most patients.
There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. Apply only to the skin of the upper eyelid margin at the base of the eyelashes.
LATISSE® should be used with caution in patients with active intraocular inflammation, such as uveitis, because the inflammation may be exacerbated.
The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms and erythema of the eyelid. These events occurred in less than 4% of patients.
The following reactions have been identified during postmarketing use of LATISSE® in clinical practice: burning sensation of the eyelid, periorbital erythema, eye swelling, eyelid irritation, eyelid edema, eyelid pruritus, iris hyperpigmentation, increased lacrimation, madarosis and trichorrhexis (temporary loss of a few eyelashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), rash (including macular, erythematous and pruritic, limited to the eyelids and periorbital region), periorbital skin discolouration, and blurred vision.
Use in pediatric patients below the age of 16 years is not recommended because of potential safety concerns related to increased pigmentation following long-term chronic use.
Please ask us for the full Prescribing Information at your consultation.
Ask us about cosmetic treatments
Our certified doctors and nurse injectors have a great deal of experience with all of these options, and we will talk through which combination makes sense for you — including whether none of them does.